Serum N-glycan profiles differ for various breast cancer subtypes

Area of Science:

• Biochemistry
• Oncology
• Proteomics

Background:

• Breast cancer is the most common cancer in women, necessitating effective early detection methods.
• Current mammography screening has limitations in sensitivity, driving research into alternative biomarkers like blood tests.
• Serum protein N-glycosylation is being explored as a potential non-invasive biomarker for cancer detection.

Purpose of the Study:

• To investigate the biomarker potential of total serum N-glycosylation for breast cancer detection.
• To compare N-glycan profiles in breast cancer patients versus healthy individuals.
• To analyze if N-glycomic signatures vary across different breast cancer subtypes.

Main Methods:

• An age-matched case-control study involving 145 breast cancer patients and 171 healthy individuals.
• Enzymatic release and chemical derivatization of N-glycans from serum, followed by high-resolution mass spectrometry.
• Logistic regression analysis to identify associations between N-glycans and breast cancer status.

Main Results:

• Three significant associations were identified: lower levels of two triantennary glycans and higher levels of one tetraantennary glycan in cancer patients.
• Previously reported N-glycomic signatures were not consistently replicated, suggesting cohort heterogeneity.
• Serum N-glycan profiles demonstrated differences across various analyzed breast cancer subtypes.

Conclusions:

• Total serum N-glycosylation analysis holds promise as a biomarker for breast cancer detection.
• Specific N-glycan alterations are associated with breast cancer, but replication requires careful cohort consideration.
• The heterogeneity of breast cancer is reflected in distinct serum N-glycan profiles among subtypes.